Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis.
Kenny HA, Leonhardt P, Ladanyi A, Yamada SD, Montag A, Im HK, Jagadeeswaran S, Shaw DE, Mazar AP, Lengyel E.
Kenny HA, et al. Among authors: lengyel e.
Clin Cancer Res. 2011 Feb 1;17(3):459-71. doi: 10.1158/1078-0432.CCR-10-2258. Epub 2010 Dec 13.
Clin Cancer Res. 2011.
PMID: 21149615
Free PMC article.